Literature DB >> 4939737

Preclinical assessment of the antibacterial activity of nebramycin factor 6.

D A Preston, W E Wick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4939737

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother (Bethesda)


× No keyword cloud information.
  26 in total

1.  Sensitivity of strains of enteropathogenic Escherichia coli to tobramycin and other antibiotics.

Authors:  N Konforti; B Lev; N Hanner
Journal:  Med Microbiol Immunol       Date:  1977-12-27       Impact factor: 3.402

2.  Efficacy and pharmacokinetics of tobramycin in patients with chronic urinary tract infections and various degrees of renal impairment.

Authors:  S R Westenfelder; G Welling; P O Madsen
Journal:  Infection       Date:  1974       Impact factor: 3.553

3.  Surface manifestations of antibiotic-induced alterations in protein synthesis in bacterial cells.

Authors:  A S Klainer; R L Perkins
Journal:  Antimicrob Agents Chemother       Date:  1972-02       Impact factor: 5.191

4.  In vitro susceptibility testing with tobramycin.

Authors:  S Shadomy; C Kirchoff
Journal:  Antimicrob Agents Chemother       Date:  1972-05       Impact factor: 5.191

5.  Tobramycin: in vitro activity and comparison with kanamycin and gentamicin.

Authors:  V E Del Bene; W E Farrar
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

6.  In vitro antibiotic susceptibility of pseudomonads other than Pseudomonas aeruginosa recovered from cancer patients.

Authors:  M R Moody; V M Young; D M Kenton
Journal:  Antimicrob Agents Chemother       Date:  1972-11       Impact factor: 5.191

7.  In vitro studies of tobramycin, an aminoglycoside antibiotic.

Authors:  J Dienstag; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1972-01       Impact factor: 5.191

8.  Comparative activity of sisomicin, gentamicin, kanamycin, and tobramycin.

Authors:  J A Waitz; E L Moss; C G Drube; M J Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

9.  Comparative activity of tobramycin and gentamicin against Pseudomonas, Proteus and Providencia species.

Authors:  I B Ducan; J L Penner
Journal:  Can Med Assoc J       Date:  1975-07-12       Impact factor: 8.262

10.  Therapy of Pseudomonas aeruginosa infections with tobramycin.

Authors:  D C Blair; F R Fekety; B Bruce; J Silva; G Archer
Journal:  Antimicrob Agents Chemother       Date:  1975-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.